Variant report
Variant | esv274906 |
---|---|
Chromosome Location | chr4:86179783-86184812 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538095230 | chr4:86179819-86179820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551489161 | chr4:86179898-86179899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79907264 | chr4:86179948-86179949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12502364 | chr4:86179966-86179967 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs538912664 | chr4:86179978-86179979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11934914 | chr4:86180067-86180068 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs572361685 | chr4:86180081-86180082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542767246 | chr4:86180110-86180111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532916007 | chr4:86180138-86180139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140907110 | chr4:86180164-86180165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550462318 | chr4:86180222-86180223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576610264 | chr4:86180278-86180279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs72652194 | chr4:86180335-86180336 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs7688124 | chr4:86180357-86180358 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs555990146 | chr4:86180408-86180409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533284987 | chr4:86180475-86180476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551602556 | chr4:86180514-86180515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7688707 | chr4:86180616-86180617 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs527322462 | chr4:86180632-86180633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142854363 | chr4:86180651-86180652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567051599 | chr4:86180655-86180656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10611899 | chr4:86180737-86180738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200129849 | chr4:86180741-86180742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145039291 | chr4:86180803-86180804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528140191 | chr4:86180882-86180883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146379253 | chr4:86180925-86180926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368261720 | chr4:86180928-86180929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549978426 | chr4:86180947-86180948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571480033 | chr4:86180950-86180951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566814758 | chr4:86180954-86180955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs60520068 | chr4:86180970-86180971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138970603 | chr4:86181022-86181023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35135876 | chr4:86181026-86181027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554409169 | chr4:86181031-86181032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7689227 | chr4:86181091-86181092 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs141538925 | chr4:86181092-86181093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181595693 | chr4:86181110-86181111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79164304 | chr4:86181148-86181149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78578004 | chr4:86181166-86181167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556393759 | chr4:86181196-86181197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34245404 | chr4:86181229-86181230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577871833 | chr4:86181232-86181233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563284393 | chr4:86181247-86181248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544867303 | chr4:86181270-86181271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185867178 | chr4:86181320-86181321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543423937 | chr4:86181331-86181332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191230237 | chr4:86181332-86181333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530569283 | chr4:86181398-86181399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560515231 | chr4:86181411-86181412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563196954 | chr4:86181472-86181473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:86179400-86180600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr4:86180600-86181800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:86181800-86183000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:86183200-86183400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |